Products sold at a familiar store can feel safe simply because they are easy to buy. But for people purchasing concentrated kratom products, that assumption can carry serious consequences. In reporting by The Sentinel, Wendi Bedard, executive director of Avenues Recovery Center in Dublin, joined New Hampshire medical experts to discuss kratom, concentrated 7-hydroxymitragynine—commonly called 7-OH—and the risks facing consumers.Her message highlights an important concern: people may begin using these products without understanding their potential for dependence or recognizing when professional support is needed.
Kratom is a plant native to Southeast Asia. Its leaves contain compounds including mitragynine and small amounts of 7-OH. These compounds interact with the body in ways that can produce stimulant-like or opioid-like effects.The term “synthetic kratom” often describes products containing chemically converted or enhanced concentrations of kratom-related compounds. However, that label can obscure important differences between traditional plant material and concentrated formulations.The FDA specifically distinguishes natural kratom leaf from products containing added or enhanced levels of 7-OH. These concentrated products should not be assumed to have the same composition or risks as the leaf itself.For consumers, the practical takeaway is straightforward: two products marketed with the word “kratom” may be very different.
The Sentinel’s reporting describes kratom-related products available through gas stations, smoke shops, convenience stores, and online sellers. That accessibility can make it easier to underestimate their effects.Bedard explained that Avenues Recovery has treated people struggling with kratom addiction. Some arrived without initially realizing that the product they were using could become difficult to stop.“Because it’s so easily accessible, people are coming in, using it, not realizing the effects,” Bedard told The Sentinel.Her observations underscore the need for conversations about substances that may not look like conventional drugs. A small bottle, tablet package, or product promoted as plant-derived can still deserve serious attention during an addiction assessment.
Yes. Kratom use can be associated with substance use disorder, and concentrated 7-OH products present particular concerns. Research on kratom use disorder has documented patterns including cravings, tolerance, unsuccessful attempts to quit, and withdrawal. These experiences can interfere with daily life and make stopping more challenging than someone expected. Physical dependence and addiction are related but different. Dependence involves the body adapting to a substance. Addiction involves a pattern of use that becomes difficult to control despite harmful consequences. A person does not need to wait until their situation feels catastrophic to seek an evaluation. Repeatedly using more than intended, feeling unable to cut back, or organizing the day around access to a product are reasons to speak with a qualified professional.
The FDA warns that enhanced 7-OH products have not been established as safe or effective for medical use. Reported harms include addiction, seizures, sleep problems, gastrointestinal distress, and withdrawal symptoms such as body aches, fatigue, irritability, and cold sweats. An FDA scientific assessment also identifies respiratory depression, physical dependence, and opioid-like withdrawal as concerns associated with 7-OH. These risks make honest communication with healthcare professionals essential. Share the product name, packaging, frequency of use, and any other medications or substances being taken. If someone becomes unresponsive or has difficulty breathing, call 911 immediately.
Some people use kratom hoping to manage pain, cravings, or opioid withdrawal. However, using a product for that purpose does not establish that it is an effective treatment. Bedard told The Sentinel that Avenues does not recommend kratom as a substitute for conventional opioid addiction treatment. The FDA likewise states that no 7-OH products are approved to treat opioid withdrawal or any other medical condition. People seeking relief should discuss established treatment options with a healthcare professional. Someone who began using kratom while trying to stop another substance deserves support without judgment. Understanding that original goal can help guide a more appropriate treatment conversation.
For individuals and families in Dublin and surrounding New Hampshire communities, recognizing a concern is a meaningful first step. A professional assessment can explore substance use, withdrawal symptoms, mental health needs, and the level of support that may be appropriate. Treatment planning should address the whole person, including the reasons substance use began and the challenges that keep it going. Avenues Recovery Center in Dublin can be a starting point for a conversation about addiction treatment and next steps. Contact the team to discuss your concerns and ask about available services. Whether the concern involves kratom, concentrated 7-OH, alcohol, or another substance, reaching out creates an opportunity to move toward recovery with informed support.